Novel Prognostic Model Based on Immune Signature for Head and Neck Squamous Cell Carcinoma.

Yingying Wang Yu Xu Qingquan HuaYang JiangPeiqiang LiuWei ZhangRong Xiang

Published in: BioMed research international (2020)

Our prognostic model based on the immune signature could effectively predict the prognosis of HNSCC patients, providing novel predictive biomarkers and potential therapeutic targets for HNSCC patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
risk assessment
climate change